BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum

  May 14, 2026

   · 

  1 min read
• Press Releases

  BioSyent Declares Second Quarter 2026 Dividend

  May 14, 2026

   · 

  1 min read
• Press Releases

  Atrium Therapeutics Reports First Quarter 2026 Financial Results

  May 14, 2026

   · 

  11 min read
• Press Releases

  Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update

  May 14, 2026

   · 

  18 min read
• Press Releases

  Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

  May 14, 2026

   · 

  9 min read
• Press Releases

  Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

  May 14, 2026

   · 

  5 min read
• Press Releases

  Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 14, 2026

  May 14, 2026

   · 

  2 min read
• Press Releases

  Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

  May 14, 2026

   · 

  3 min read
• Press Releases

  Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference 2026

  May 14, 2026

   · 

  1 min read
• Press Releases

  Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet

  May 14, 2026

   · 

  2 min read